{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:53:13Z","timestamp":1790250793804,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.amjcard.2017.02.033","type":"journal-article","created":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T02:39:56Z","timestamp":1488249596000},"page":"1500-1506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effect of Tailored Antiplatelet Therapy to Reduce Recurrent Stent Thrombosis and Cardiac Death After a First Episode of Stent Thrombosis"],"prefix":"10.1016","volume":"119","author":[{"given":"Thea C.","family":"Godschalk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Willemsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastiaan","family":"Zwart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas O.","family":"Bergmeijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Willem A.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes C.","family":"Kelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian M.","family":"Hackeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurri\u00ebn M.","family":"ten Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2017.02.033_bib1","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jcin.2011.10.013","article-title":"Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis","volume":"5","author":"Armstrong","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2017.02.033_bib2","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1016\/j.jacc.2011.12.042","article-title":"Clinical outcomes following stent thrombosis occurring in-hospital versus out-of-hospital: results from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trial","volume":"59","author":"Dangas","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2017.02.033_bib3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1253\/circj.CJ-13-0780","article-title":"Comparison of long-term outcome after percutaneous coronary intervention for stent thrombosis between early, late, and very late stent thrombosis","volume":"78","author":"Kubo","year":"2014","journal-title":"Circ J"},{"key":"10.1016\/j.amjcard.2017.02.033_bib4","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.jacc.2007.10.057","article-title":"Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpanol sobre TROmbosis de stents FArmacoactivos)","volume":"51","author":"de la Torre-Hernandez","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2017.02.033_bib5","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.108.799403","article-title":"Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases","volume":"119","author":"van Werkum","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2017.02.033_bib6","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/j.1538-7836.2011.04255.x","article-title":"A\u00a0case-control study on platelet reactivity in patients with coronary stent thrombosis","volume":"9","author":"Bouman","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.amjcard.2017.02.033_bib7","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.jacc.2011.06.059","article-title":"Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data","volume":"58","author":"Brar","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2017.02.033_bib8","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1161\/CIRCULATIONAHA.111.029165","article-title":"Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: impact on Thrombosis and Safety (GRAVITAS) trial","volume":"124","author":"Price","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2017.02.033_bib9","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/j.jacc.2012.02.026","volume":"59","author":"Trenk","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2017.02.033_bib10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ahj.2010.09.029","volume":"161","author":"Collet","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2017.02.033_bib11","doi-asserted-by":"publisher","first-page":"617098","DOI":"10.1155\/2012\/617098","article-title":"Towards personalized medicine based on platelet function testing for stent thrombosis patients","volume":"2012","author":"Godschalk","year":"2012","journal-title":"Thrombosis"},{"key":"10.1016\/j.amjcard.2017.02.033_bib12","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2017.02.033_bib13","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1001\/jama.2010.181","article-title":"Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation","volume":"303","author":"Breet","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2017.02.033_bib14","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1111\/j.1538-7836.2007.02609.x","article-title":"Vasodilator-stimulated phosphoprotein phosphorylation analysis prior to percutaneous coronary intervention for exclusion of postprocedural major adverse cardiovascular events","volume":"5","author":"Bonello","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.amjcard.2017.02.033_bib15","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1016\/j.ijcard.2012.05.100","article-title":"Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: systematic review and meta-analysis","volume":"167","author":"Aradi","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2017.02.033_bib16","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1136\/heartjnl-2011-301164","article-title":"Personalised antiplatelet therapy in stent thrombosis: observations from the Clopidogrel Resistance in Stent Thrombosis (CREST) registry","volume":"98","author":"Sambu","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2017.02.033_bib17","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.2146\/ajhp080129","article-title":"Overview of advances in cardiovascular disease treatment and prevention: the evolving role of antiplatelet therapy","volume":"65","author":"Talbert","year":"2008","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.amjcard.2017.02.033_bib18","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3109\/09537104.2013.836175","article-title":"Evolving pattern of platelet P2Y12 inhibition in patients with acute coronary syndromes","volume":"25","author":"Joshi","year":"2014","journal-title":"Platelets"},{"key":"10.1016\/j.amjcard.2017.02.033_bib19","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/eurheartj\/ehs036","article-title":"Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction","volume":"33","author":"Kalesan","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2017.02.033_bib20","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1161\/CIRCINTERVENTIONS.113.000415","article-title":"Outcomes with various drug-eluting or bare metal stents in patients with ST-segment-elevation myocardial infarction: a mixed treatment comparison analysis of trial level data from 34 068 patient-years of follow-up from randomized trials","volume":"6","author":"Bangalore","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2017.02.033_bib21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1160\/TH13-01-0057","article-title":"Clopidogrel pretreatment in primary percutaneous coronary intervention: prevalence of high on-treatment platelet reactivity and impact on preprocedural patency of the infarct-related artery","volume":"110","author":"Ferreiro","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjcard.2017.02.033_bib22","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1161\/CIRCINTERVENTIONS.112.972323","article-title":"Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction","volume":"5","author":"Alexopoulos","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2017.02.033_bib23","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.amjcard.2016.02.012","article-title":"Trends in P2Y12 inhibitor use in patients referred for invasive evaluation of coronary artery disease in contemporary US practice","volume":"117","author":"Fan","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2017.02.033_bib24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/2048872614565912","article-title":"Opportunities for improvement in anti-thrombotic therapy and other strategies for the management of acute coronary syndromes: insights from EPICOR, an international study of current practice patterns","volume":"5","author":"Bueno","year":"2016","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.amjcard.2017.02.033_bib25","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"61","author":"O'Gara","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2017.02.033_bib26","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2017.02.033_bib27","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2017.02.033_bib28","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2017.02.033_bib29","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2017.02.033_bib30","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(09)62191-7","article-title":"Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study","volume":"375","author":"Cannon","year":"2010","journal-title":"Lancet"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914917302199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914917302199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T20:29:15Z","timestamp":1536006555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914917302199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0002914917302199"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2017.02.033","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Tailored Antiplatelet Therapy to Reduce Recurrent Stent Thrombosis and Cardiac Death After a First Episode of Stent Thrombosis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2017.02.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}